ArticleMMWR. Morbidity and mortality weekly report2021
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020-February 14, 2021.
Article in MMWR. Morbidity and mortality weekly report, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed.
- Evaluation of Google search trends for COVID-19 vaccination administration efforts within an urban department of public health.Journal of public health research · 2026Article
- A descriptive investigation of the impact of statewide distribution policies and consumer vulnerabilities on COVID-19 vaccination in the united States.Health care management science · 2025Article
- No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations.Nature communications · 2025Article
- The effect of COVID vaccination timing on the seroprevalence of IgG antibodies: evidence from the Guayas region of Ecuador.Frontiers in public health · 2025Article
- Variation in the time to complete the primary COVID-19 vaccine series by race, ethnicity, and geography among older US adults.Vaccine · 2025Observational
- Recognising the heterogeneity of Indigenous Peoples during the COVID-19 pandemic: a scoping review across Canada, Australia, New Zealand and the USA.BMJ public health · 2024Article
- Review
- Tailoring COVID-19 Vaccination Strategies in High-Seroprevalence Settings: Insights from Ethiopia.Vaccines · 2024Article
- Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore's Experience.Health affairs (Project Hope) · 2024Article
- Estimated public health impact of concurrent mask mandate and vaccinate-or-test requirement in Illinois, October to December 2021.BMC public health · 2024Article
- Comparative effectiveness of alternative intervals between first and second doses of the mRNA COVID-19 vaccines.Nature communications · 2024Article
- Article
- Dynamic predictors of COVID-19 vaccination uptake and their interconnections over two years in Hong Kong.Nature communications · 2024Article
- Insights from qualitative and bifurcation analysis of COVID-19 vaccination model in Bangladesh.PloS one · 2024Article
- Article
- Article
- Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III).Vaccines · 2023Article
- Global Implications for COVID-19 Vaccine Series Completion: Insights from Real-World Data from the United States.Vaccines · 2022Article
- Article
- Knowledge, Attitude, Practices, and Vaccine Hesitancy Among the Latinx Community in Southern California Early in the COVID-19 Pandemic: Cross-sectional Survey.JMIR formative research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In December 2020, two COVID-19 vaccines (Pfizer-BioNTech and Moderna) received Emergency Use Authorization from the Food and Drug Administration.*
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.